D.Western Therapeutics Institute

4576.TTSE GROWTHPharmaceutical

Key numbers · FY ended 2025-12

Revenue¥388m-17.8% YoY Operating income−¥620m—Net income (owners)−¥632m—Total assets¥2.2bn+30.0% YoY EPS (basic)¥-13.19+64.1% YoY

Full financial history and reports →

Stock price4576 · View chart ↗

Open the price chart on TradingView.

Latest filings

Thu, Nov 5 · JST1 filing

16:005% STAKED.Western Therapeutics Institute · Growth Capital Inc. · 42.96% → 41.90%−1.06pp

Thu, Oct 8 · JST1 filing

16:005% STAKED.Western Therapeutics Institute · Growth Capital Inc. · 42.96%new 42.96%

Wed, May 13 · JST1 filing

11:065% STAKED.Western Therapeutics Institute · HIDAKA YUUICHI · 11.07% → 9.00%−2.07pp

Tue, Jan 27 · JST1 filing

16:085% STAKED.Western Therapeutics Institute · HIDAKA YUUICHI · 12.11% → 11.07%−1.04pp

Thu, Oct 2 · JST1 filing

15:415% STAKED.Western Therapeutics Institute · SBI SECURITIES Co., Ltd. · 11.38% → 7.28%−4.10pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
HIDAKA YUUICHI	9.73%	-1.34pp	2026-09-15

Each holder's own ratio from its most recent large-shareholding report.